Retinopathy of prematurity: is genetic predisposition an important risk factor?

References

• Haines JL, Fielder A, Baker H, Wilkinson AR. UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome. Arch. Dis. Child. Fetal Neonatal Ed.90, 240–244 (2005).
   Web of Science ®Google Scholar
• Kaiser RS, Trese MT, Williams GA, Cox MS. Adult retinopathy of prematurity: outcomes of rhegmatogenous retinal detachments and retinal tears. Ophthalmology108, 1647–1653 (2001).
   PubMed Web of Science ®Google Scholar
• Gilbert C, Fielder A, Gordillo L et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics115, e518–e525 (2005).
   PubMed Web of Science ®Google Scholar
• Tompkins C. A sudden rise in the prevalence of retinopathy of prematurity blindness? Pediatrics108, 526–526 (2001).
   PubMedGoogle Scholar
• Palmer EA. Implications of the natural course of retinopathy of prematurity. Pediatrics111, 885–886 (2003).
   PubMedGoogle Scholar
• Holmstrom GE, Broberger U, Thomassen P. Neonatal risk factors for retinopathy of prematurity – a population- based study. Acta Ophthalmol. Scand.76, 204–207 (1998).
   PubMedGoogle Scholar
• Karna P, Muttineni J, Angell L, Karmaus W. Retinopathy of prematurity and risk factors: a prospective cohort study. BMC Pediatr.5, 18 (2005).
   PubMedGoogle Scholar
• Wheatley CM, Dickinson JL, Mackey DA, Craig JE, Sale MM. Retinopathy of prematurity: recent advances of our understanding. Arch. Dis. Child Fetal Neonatal Ed.87, F78–F82 (2002).
   PubMed Web of Science ®Google Scholar
• Schaffer DB, Palmer EA, Plotsky DF et al. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology100, 230–237 (1993).
   PubMed Web of Science ®Google Scholar
• Hutchinson AK, O’Neil JW, Morgan EN, Cervenak MA, Saunders RA. Retinopathy of prematurity in infants with birth weights greater than 1250 grams. J. AAPOS7, 190–194 (2003).
   PubMed Web of Science ®Google Scholar
• Saunders RA, Donahue ML, Christmann LM et al. Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch. Ophthalmol.115, 604–608 (1997).
   PubMedGoogle Scholar
• Arnold RW, Kesler K, Avila E. Susceptibility to retinopathy of prematurity in Alaskan Natives. J. Pediatr. Ophthalmol. Strabismus31, 192–194 (1994).
   PubMed Web of Science ®Google Scholar
• Leo SW, Cheong PY. Incidence of retinopathy of prematurity in Singapore. Singapore Med. J.38, 54–57 (1997).
   PubMedGoogle Scholar
• Bizzarro MJ, Hussain N, Jonsson B et al. Genetic susceptibility to retinopathy of prematurity. Pediatrics118, 1858–1863 (2006).
   PubMed Web of Science ®Google Scholar
• Fukai N, Eklund L, Marneros AG et al. Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J.21, 1535–1544 (2002).
   PubMed Web of Science ®Google Scholar
• Sertie AL, Sossi V, Camargo AA, Zatz M, Brahe C, Passos-Bueno MR. Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Hum. Mol. Genet.9, 2051–2058 (2000).
   PubMed Web of Science ®Google Scholar
• Rogers MS, D’Amato RJ. The effect of genetic diversity on angiogenesis. Exp. Cell Res.312, 561–574 (2006).
   PubMed Web of Science ®Google Scholar
• Omoto S, Hayashi T, Kitahara K, Takeuchi T, Ueoka Y. Autosomal dominant familial exudative vitreoretinopathy in two Japanese families with FZD4 mutations (H69Y and C181R). Ophthalmic Genet.25, 81–90 (2004).
   PubMedGoogle Scholar
• Downey LM, Keen TJ, Roberts E, Mansfield DC, Bamashmus M, Inglehearn CF. A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12–13. Am. J. Hum. Genet.68, 778–781 (2001).
   PubMed Web of Science ®Google Scholar
• Drenser KA, Dailey W, Capone A, Trese MT. Genetic evaluation to establish the diagnosis of X-linked familial exudative vitreoretinopathy. Ophthalmic Genet.27, 75–78 (2006).
   PubMed Web of Science ®Google Scholar
• Riveiro-Alvarez R, Trujillo-Tiebas MJ, Gimenez-Pardo A et al. Genotype–phenotype variations in five Spanish families with Norrie disease or X-linked FEVR. Mol. Vis.11, 705–712 (2005).
   PubMed Web of Science ®Google Scholar
• de Crecchio G, Simonelli F, Nunziata G et al. Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity. Clin. Genet.54, 315–320 (1998).
   PubMed Web of Science ®Google Scholar
• Toomes C, Bottomley HM, Jackson RM et al. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am. J. Hum. Genet.74, 721–730 (2004).
   PubMed Web of Science ®Google Scholar
• Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis: a look outside the nucleus. Science287, 1606–1609 (2000).
   PubMed Web of Science ®Google Scholar
• Jiao X, Ventruto V, Trese MT, Shastry BS, Hejtmancik JF. Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5. Am. J. Hum. Genet.75, 878–884 (2004).
   PubMed Web of Science ®Google Scholar
• Downey LM, Bottomley HM, Sheridan E et al. Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5. Br. J. Ophthalmol.90, 1163–1167 (2006).
   PubMed Web of Science ®Google Scholar
• MacDonald ML, Goldberg YP, Macfarlane J, Samuels ME, Trese MT, Shastry BS. Genetic variants of frizzled-4 gene in familial exudative vitreoretinopathy and advanced retinopathy of prematurity. Clin. Genet.67, 363–366 (2005).
   PubMed Web of Science ®Google Scholar
• Sims KB, Lebo R V, Benson G et al. The Norrie disease gene maps to a 150 kb region on chromosome Xp11.3. Hum. Mol. Genet.1, 82–83 (1992).
   Google Scholar
• Shastry BS, Pendergast SD, Hartzer MK, Liu X, Trese MT. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch. Ophthalmol.115, 651–655 (1997).
   PubMed Web of Science ®Google Scholar
• Buffenn AN, Bernstein SL, Hutcheson KA. Identification of a new Norrie disease gene mutation in an African-American infant with advanced retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci.40, S565 (1999).
   Google Scholar
• Haider MZ, Devarajan LV, Al Essa M et al. Retinopathy of prematurity: mutations in the Norrie disease gene and the risk of progression to advanced stages. Pediatr. Int.43, 120–123 (2001).
   PubMed Web of Science ®Google Scholar
• Haider MZ, Devarajan LV, Al Essa M, Kumar H. A C597 – a polymorphism in the Norrie disease gene is associated with advanced retinopathy of prematurity in premature Kuwaiti infants. J. Biomed. Sci.9, 365–370 (2002).
   PubMed Web of Science ®Google Scholar
• Hiraoka M, Berinstein DM, Trese MT, Shastry BS. Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity. J. Hum. Genet.46, 178–181 (2001).
   PubMed Web of Science ®Google Scholar
• Talks SJ, Ebenezer N, Hykin P et al. De novo mutations in the 5' regulatory region of the Norrie disease gene in retinopathy of prematurity. J. Med. Genet.38, E46 (2001).
   PubMedGoogle Scholar
• Hutcheson KA, Paluru PC, Bernstein SL et al. Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. Mol. Vis.11, 501–508 (2005).
   PubMed Web of Science ®Google Scholar
• Dickinson JL, Sale MM, Passmore A et al. Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity. Clin. Experiment. Ophthalmol.34, 682–688 (2006).
   PubMed Web of Science ®Google Scholar
• Nallathambi J, Shukla D, Rajendran A, Namperumalsamy P, Muthulakshmi R, Sundaresan P. Identification of novel FZD4 mutations in Indian patients with familial exudative vitreoretinopathy. Mol. Vis.12, 1086–1092 (2006).
   PubMed Web of Science ®Google Scholar
• Qin M, Hayashi H, Oshima K, Tahira T, Hayashi K, Kondo H. Complexity of the genotype–phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes. Hum. Mutat.26, 104–112 (2005).
   PubMed Web of Science ®Google Scholar
• Yoshida S, Arita R, Yoshida A et al. Novel mutation in FZD4 gene in a Japanese pedigree with familial exudative vitreoretinopathy. Am. J. Ophthalmol.138, 670–671 (2004).
   PubMed Web of Science ®Google Scholar
• Toomes C, Downey LM, Bottomley HM et al. Identification of a fourth locus (EVR4) for familial exudative vitreoretinopathy (FEVR). Mol. Vis.10, 37–42 (2004).
   PubMed Web of Science ®Google Scholar
• Helminger G, Endo M, Ferrara N, Hlatky L, Jain RK. Formation of endothelial cell networks. Nature405, 139–141 (2000).
   Google Scholar
• Wei MH, Popescu NC, Lerman MI, Merrill MJ, Zimonjic DB. Localization of the human vascular endothelial growth factor gene, VEGF, at chromosome 6p12. Hum. Genet.97, 794–797 (1996).
   PubMed Web of Science ®Google Scholar
• Makino Y, Cao R, Svensson K et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature414, 550–554 (2001).
   PubMed Web of Science ®Google Scholar
• Pierce EA, Folez ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch. Ophthalmol.114, 1219–1228 (1996).
   PubMedGoogle Scholar
• Leske DA, Wu J, Mookadam M et al. The relationship of retinal VEGF and retinal IGF-1 mRNA with neovascularization in an acidosis-induced model of retinopathy of prematurity. Curr. Eye Res.31, 163–169 (2006).
   PubMed Web of Science ®Google Scholar
• Leske DA, Wu J, Fautsch MP et al. The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP. Mol. Vis.10, 43–50 (2004).
   PubMed Web of Science ®Google Scholar
• Werdich XQ, McCollum GW, Rajaratnam VS, Penn JS. Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy. Exp. Eye Res.79, 623–630 (2004).
   PubMed Web of Science ®Google Scholar
• McLeod DS, Taomoto M, Cao J, Zhu Z, Witte L, Lutty GA. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci.43, 474–482 (2002).
   PubMed Web of Science ®Google Scholar
• Ferrara N, Damico L, Shams N, Lowman H, Kim R. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina26, 859–870 (2006).
   PubMed Web of Science ®Google Scholar
• Moshfeghi AA, Rosenfeld PJ, Puliafito CA et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study. Ophthalmology113, 2002–2012 (2006).
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Rich RM, Lalwani GA. Ranibizumab: Phase III clinical trial results. Ophthalmol. Clin. North Am.19, 361–372 (2006).
   PubMedGoogle Scholar
• Vannay A, Dunai G, Banyasz I et al. Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr. Res.57, 396–398 (2005).
   PubMed Web of Science ®Google Scholar
• Watson CJ, Webb NJ, Bottomley MJ, Brenchley P. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine12, 1232–1235 (2000).
   PubMed Web of Science ®Google Scholar
• Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J. Vasc. Res.37, 443–448 (2000).
   PubMed Web of Science ®Google Scholar
• Awata T, Inoue K, Kurihara S et al. A common polymorphism in the 5´ untranslated region of the VEGF gene is associated with diabetic retinopathy in Type 2 diabetes. Diabetes51, 1635–1639 (2002).
   PubMed Web of Science ®Google Scholar
• Awata T, Kurihara S, Takata N et al. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in Type 2 diabetes. Biochem. Biophys. Res. Commun.333, 679–685 (2005).
   PubMed Web of Science ®Google Scholar
• Suganthalakshmi B, Anand R, Kim R et al. Association of VEGF and eNOS gene polymorphisms in Type 2 diabetic retinopathy. Mol. Vis.12, 336–341 (2006).
   PubMed Web of Science ®Google Scholar
• Banyasz I, Bokodi G, Vannay A et al. Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity. Curr. Eye Res.31, 685–690 (2006).
   PubMed Web of Science ®Google Scholar
• Cooke RW, Drury JA, Mountford R, Clark D. Genetic polymorphisms and retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci.45, 1712–1715 (2004).
   PubMed Web of Science ®Google Scholar
• Kwinta P, Mitkowska Z, Tomasik T, Bik-Multanowski M, Pietrzyk JJ. Vascular endothelial growth factor gene polymorphisms and the risk of retinopathy of prematurity. Pediatr. Res.56, 465–511 (2004).
   Google Scholar
• Shastry BS, Qu X. Lack of association of the VEGF gene promoter (-634 G –>C and H460 C–>T) polymorphism and the risk of advanced retinopathy of prematurity. Graefes Arch. Clin. Exp. Ophthalmol. DOI: 10.1007/s00417-006-0480-6 (2006) (Epub ahead of print).
   PubMedGoogle Scholar
• Sennlaub F, Chemtob S. VEGFR-1: a safe target for prophylaxis of retinopathy of prematurity? Pediatr. Res.55, 1–2 (2004).
   PubMedGoogle Scholar
• Kariyazono H, Ohno T, Khajoee V et al. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr. Res.56, 953–959 (2004).
   PubMed Web of Science ®Google Scholar
• Lofqvist C, Engstrom E, Sigurdsson J et al. Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor H1 deficit. Pediatrics117, 1930–1938 (2006).
   PubMed Web of Science ®Google Scholar
• Hellstrom A, Engstrom E, Hard AL et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics112, 1016–1020 (2003).
   PubMed Web of Science ®Google Scholar
• Smith LE. IGF-1 and retinopathy of prematurity in the preterm infant. Biol. Neonate88, 237–244 (2005).
   PubMedGoogle Scholar
• ‘t Hart LM, Fritsche A, Rietveld I et al. Genetic factors and insulin secretion: gene variants in the IGF genes. Diabetes53(Suppl. 1), S26–S30 (2004).
   Google Scholar
• Al Zahrani A, Sandhu MS, Luben RN et al. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum. Mol. Genet.15, 1–10 (2006).
   PubMed Web of Science ®Google Scholar
• Johnston LB, Dahlgren J, Leger J et al. Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations. J. Clin. Endocrinol. Metab.88, 4805–4810 (2003).
   PubMed Web of Science ®Google Scholar
• te Velde SJ, van Rossum EF, Voorhoeve PG et al. An IGF-I promoter polymorphism modifies the relationships between birth weight and risk factors for cardiovascular disease and diabetes at age 36. BMC Endocr. Disord.5, 5 (2005).
   PubMedGoogle Scholar
• Frayling TM, Hattersley AT, McCarthy A et al. A putative functional polymorphism in the IGF-I gene: association studies with Type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes51, 2313–2316 (2002).
   PubMed Web of Science ®Google Scholar
• Rietveld I, Ikram MK, Vingerling JR et al. An IGF-I gene polymorphism modifies the risk of diabetic retinopathy. Diabetes55, 2387–2391 (2006).
   PubMed Web of Science ®Google Scholar
• Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Kobylarz J, Pietrzyk JJ. Retinopathy of prematurity: is genetic predisposition an important risk factor? Invest. Ophthalmol. Vis. Sci. (2006) (In press).
   Google Scholar
• Balogh A, Derzbach L, Vannay A, Vasarhelyi B. Lack of association between insulin-like growth factor I receptor G(+3174)A polymorphism and retinopathy of prematurity. Graefes Arch. Clin. Exp. Ophthalmol.244, 1035–1038 (2006).
   PubMed Web of Science ®Google Scholar
• Li B, Khanna A, Sharma V, Singh T, Suthanthiran M, August P. TGF-b1 DNA polymorphism, protein levels, and blood pressure. hypertension 33, 271–275 (1999).
   Google Scholar
• Beranek M, Kankova K, Benes P et al. Polymorphism R25P in the gene encoding transforming growth factor-β (TGF- β1) is a newly identified risk factor for proliferative diabetic retinopathy. Am. J. Med. Genet.109, 278–283 (2002).
   PubMed Web of Science ®Google Scholar
• Mazaheri S, Hajilooi M, Rafiei A. The G-308A promoter variant of the tumor necrosis factor-α gene is associated with migraine without aura. J. Neurol.253(12), 1589–1593 (2006).
   PubMed Web of Science ®Google Scholar
• Sykora J, Subrt I, Didek P et al. Cytokine tumor necrosis factor-α a promoter gene polymorphism at position -308 G–>A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn’s Disease. J. Pediatr. Gastroenterol. Nutr.42, 479–487 (2006).
   PubMed Web of Science ®Google Scholar
• Li YF, Gauderman WJ, Avol E, Dubeau L, Gilliland FD. Associations of tumor necrosis factor G-308A with childhood asthma and wheezing. Am. J. Respir. Crit. Care Med.173, 970–976 (2006).
   PubMed Web of Science ®Google Scholar
• Yanamandra K, Boggs P, Loggins J, Baier RJ. Interleukin-10 -1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. Pediatr. Pulmonol.39, 426–432 (2005).
   PubMed Web of Science ®Google Scholar
• Haider MZ, Devarajan LV, Al Essa M, Kumar H. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Kuwaiti children with retinopathy of prematurity. Biol. Neonate82, 84–88 (2002).
   PubMedGoogle Scholar
• Csak K, Szabo V, Szabo A, Vannay A. Pathogenesis and genetic basis for retinopathy of prematurity. Front Biosci.11, 908–920 (2006).
   PubMed Web of Science ®Google Scholar